Regulation would expand Augment's reach
Augment
Retail access would turn Augment from a niche trading venue into a distribution business. The biggest constraint in private secondaries is no longer just finding buyers, it is packaging scarce supply into structures that many more people can legally buy. Augment already does the hard part, sourcing shares, warehousing them in SPVs, handling diligence, and letting smaller investors buy slices quickly, so looser rules would mostly remove a customer cap rather than require a new product.
-
Augment has already moved down market operationally. It says 80% of its volume is still institutional, but about 80% of trades by count are now retail sized, because its SPV based flow lets users buy private names in minutes with checks as low as a few thousand dollars instead of negotiating bespoke block trades.
-
The main regulatory choke point is structure, not demand. Both Augment and Monark point to SPV investor limits as what keeps minimums high. If those caps expand, the same $10M offering can be split across far more people, pushing minimums down and making single name private stock look much more like a mainstream brokerage product.
-
That would shift competition toward who controls distribution and trust. EquityZen already uses fund structures to pool smaller investors, Monark sells private market access into brokerages and RIAs, and Augment is building a direct consumer app around sourced inventory. In a broader retail regime, the winners are likely the firms that combine supply access with the cleanest onboarding and compliance rails.
The next phase is private shares becoming a normal menu item inside brokerage and wealth accounts, not a special transaction for accredited investors. If regulation opens that door, Augment is positioned to ride the shift from high touch secondary brokerage toward app based, repeat trading in a much larger retail market.